A six-year trial involving nearly 4,750 adults at high risk for type 2 diabetes found that a calorie-reduced Mediterranean diet combined with moderate exercise lowered new diabetes diagnoses by roughly 31 percent, according to findings summarized by the Harvard T.H. Chan School of Public Health in May 2026. The PREDIMED-Plus results on diabetes incidence were published in Nature Medicine in 2024. The most striking part: the benefit held even among participants who barely lost any weight.
That detail challenges a deeply rooted assumption in diabetes prevention, where shedding pounds has long been treated as the main event. The landmark U.S. Diabetes Prevention Program, published more than two decades ago, showed that intensive lifestyle changes could cut diabetes risk by 58 percent, but much of that protection was attributed to participants losing 7 percent or more of their body weight. This newer trial suggests that what people eat and how consistently they move may matter on their own, independent of the scale.
What the PREDIMED-Plus trial actually tested
The trial, known as PREDIMED-Plus, enrolled adults in Spain who had metabolic syndrome or were overweight. Researchers randomly assigned participants to one of two groups. The intervention group followed a calorie-reduced Mediterranean diet, engaged in regular moderate physical activity such as brisk walking, and received ongoing coaching from health professionals over the full study period. The control group received general dietary advice but not the structured support.
The Mediterranean pattern emphasized vegetables, legumes, whole grains, fish, nuts, and extra-virgin olive oil. Red and processed meats, sugary beverages, and refined grains were discouraged. Calorie intake was reduced, though the precise daily target has not been specified in the publicly available summary. Exercise was moderate in intensity, the kind that raises your heart rate without requiring gym-level exertion.
Over approximately six years of follow-up, the intervention group developed type 2 diabetes at a rate roughly 31 percent lower than the control group. That 31 percent figure represents a hazard ratio from the trial’s primary analysis, meaning it accounts for the timing of diabetes onset across the full follow-up period, not just a simple comparison of final tallies. The trial’s size, randomized design, and long duration make it one of the more rigorous lifestyle-based diabetes prevention studies conducted to date.
Why the weight-loss finding matters
For decades, public health messaging around diabetes prevention has centered on weight loss, and for good reason. Excess body fat, particularly around the abdomen, drives insulin resistance, the metabolic dysfunction at the core of type 2 diabetes. But that message has also left millions of people feeling stuck. Long-term weight loss is notoriously difficult to sustain, and many who try regain most of what they lost within a few years.
The PREDIMED-Plus results offer a different frame. Participants who shed relatively little weight still saw meaningful protection against diabetes. The research team’s framing suggests that improvements in diet quality, such as higher fiber intake, healthier fats, and fewer rapidly absorbed carbohydrates, may improve how the body handles blood sugar after meals regardless of whether fat mass drops substantially. Changes in insulin sensitivity, gut microbiome composition, and chronic inflammation are all plausible pathways, though the publicly available summary does not include direct biomarker measurements confirming a specific mechanism.
This does not mean weight loss is irrelevant. It almost certainly provides additional metabolic benefit. But the trial’s results suggest that people who improve their eating patterns and stay physically active are not spinning their wheels if the number on the scale refuses to budge.
Important caveats and open questions
Several details remain unclear from the institutional summary. The exact calorie-reduction target, the prescribed minutes of weekly exercise, and a breakdown of diabetes incidence by weight-loss subgroup have not been publicly specified. Without that granular data, it is difficult to know precisely how much of the benefit came from diet quality versus calorie restriction versus physical activity versus the coaching itself.
The coaching component deserves particular attention. Participants in the intervention group received sustained professional support over six years, not a single counseling session but an ongoing relationship that helped them navigate relapses, holidays, and everyday obstacles. Lifestyle trials cannot be blinded: participants knew they were receiving extra attention, and that awareness can influence behavior in ways that go beyond the specific dietary or exercise plan. Some portion of the benefit may reflect the accountability and encouragement that came with regular professional contact.
Generalizability is another consideration. The trial population consisted of Spanish adults with metabolic syndrome or elevated body weight. Whether the same combination would produce similar results in younger populations, leaner individuals, or communities with very different baseline diets and food access is not addressed by this study. A Mediterranean-style pattern centered on produce, whole grains, and olive oil may be less feasible in settings where those foods are expensive or culturally unfamiliar.
Readers should also keep the distinction between relative and absolute risk in mind. A 31 percent relative reduction is meaningful at a population level, but the number of diabetes cases actually prevented per hundred participants depends on the baseline incidence rate, which the summary does not detail. Among adults with metabolic syndrome, baseline rates tend to be high enough that a 31 percent cut translates into a substantial real-world benefit, but the precise figure matters for individual decision-making.
How this compares to other approaches
The original Diabetes Prevention Program, the gold standard in the field, demonstrated a 58 percent reduction in diabetes risk with intensive lifestyle intervention, but that program demanded significant weight loss (a target of at least 7 percent of body weight) and 150 minutes per week of physical activity. Many participants struggled to maintain those targets over time.
More recently, GLP-1 receptor agonist medications such as semaglutide have shown potent effects on both weight loss and diabetes prevention. A 2024 analysis of the SELECT trial found that semaglutide reduced the risk of progressing to type 2 diabetes by roughly 73 percent in adults with obesity and cardiovascular disease. But these drugs are expensive, require ongoing use, and carry side effects that not everyone tolerates.
The PREDIMED-Plus trial occupies a different niche. Its intervention is lower-tech, potentially more accessible, and appears to work even without dramatic weight loss. For people who cannot access or tolerate medications, or who prefer a food-and-movement-first approach, these results provide concrete evidence that the strategy is protective.
What to do with this information
For anyone already managing elevated blood sugar or metabolic risk factors, the practical message is straightforward. A Mediterranean-style eating pattern with modestly reduced calories, paired with regular moderate activity and some form of structured accountability, produced measurable protection in a well-designed trial. The fact that this protection did not hinge on dramatic weight loss is the most actionable piece of the finding.
Starting does not require an overhaul. Swapping refined grains for whole grains, cooking with olive oil instead of butter, adding a daily 30-minute walk, and replacing sugary drinks with water are concrete, incremental steps that align with the dietary pattern tested in the trial. A conversation with a primary care provider or registered dietitian can help tailor calorie targets and activity levels to individual health status, medications, and preferences.
The trial’s use of sustained coaching over six years is worth noting for health systems and insurers, too. Brief one-time counseling sessions are far more common in clinical practice, but the PREDIMED-Plus results suggest that ongoing support, the kind that helps people troubleshoot setbacks over months and years, may be a critical ingredient in making lifestyle changes stick.
Why a diet-and-exercise strategy that works without dramatic weight loss changes the prevention conversation
Global type 2 diabetes rates continue to climb, driven by dietary shifts and sedentary routines. Weight loss remains beneficial for many health outcomes, but a prevention strategy that works even when the scale barely moves offers a more realistic path for the millions of people who have been told, repeatedly, that losing weight is the only answer. This trial does not close every gap in knowledge, but it adds strong evidence that improving what you eat, how much you eat, and how consistently you move can meaningfully shift diabetes risk, with or without a dramatic number on the scale.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
